Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Nov 11, 2015
Charles Berde, MD, PhD, chief of pain medicine at Boston Children's Hospital, describes site 1 sodium channel blockers — a novel anesthetic agent, derived from marine toxins, that he and his colleagues developed.